Seroprevalence of Toxoplasma gondii among Pregnant Women in Slovakia
Authors:
C. Studeničová 1; F. Ondriska; R. Holková 1
Authors place of work:
Parazitologický ústav LF UK, BratislavaHPL, spol. s. r. o., Bratislava
1
Published in the journal:
Epidemiol. Mikrobiol. Imunol. 57, 2008, č. 1, s. 8-13
Summary
Toxoplasmosis is caused by a protozoan parasite, Toxoplasma gondii. Primary infection with Toxoplasma gondii in pregnant women can lead to adverse outcomes. Since initially asymptomatic, toxoplasmosis is difficult to diagnose. The aims of this study were to determine the seroprevalence of toxoplasmosis in pregnant women in Slovakia and to identify possible risk factors.
As many as 145 (22.
1 %) of 656 pregnant women screened for T. gondii were seropositive. The prevalence of toxoplasmosis significantly increases with age and the highest seropositivity rate (35.4 %) was found in the age group of 35-44 years. A significantly higher seropositivity rate was observed in women living in the surroundings of Bratislava (63.5 %) as compared to Bratislava (36.6 %, p< 0.001; OR=0.53, 95 % CI=0.36-0.79)
Among the epidemiological factors, contact with soil appeared statistically significant (35.3 %, p=0.014; OR=1.67, 95 % CI=1.09-2.56). Fatigue (32.1 %, p=0.026; OR=1.84, 95 % CI=1.03-3.27), miscarriages (44.1 %, p=0.002; OR=2.22, 95 % CI=1.3-3.8) and toxoplasmosis in the family (10.7 %, p=0.002) were most commonly reported in history of the study subjects.
Key words:
Toxoplasmosis – seroprevalence – diagnosis – epidemiology - clinical manifestation.
Zdroje
1. Aspöck, H., Pollak, A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl., 1992, 84, 32–38.
2. Baril, L., Ancelle, T., Thulliez, P., Goulet, V., Carme, B. Facteurs de risique ď aquisition de la toxoplasmose chez les femmes enccintes en 1995 France. B.E.H., 1996,16, 73-75.
3. Buchy, P., Follezou, J. Y., LienTX, An. T. T., Tram, L. T. et al. Serological study of toxoplasmosis in Vietnam in a population drug users (Ho Chi Minh city) and pregnant women (Nha Trang). Bull Soc Pathol Exot, 2003, 96, 46-47.
4. Buffolano, W., Sagliocca, L., Fratta, D., Tozzi, A. et al. Prenatal toxoplasmosis screening in Campania region, Italy. Ital J Gynaecol Obstet, 1994, 3, 70-74.
5. Buxton, D. Ovine toxoplasmosis a review. J R Soc Med, 1990, 83, 509-511.
6. Cook, A. J. C., Gilbert, R. E., Buffolano, W., Zufferey, J., Petersen, E. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. BMJ, 2000, 321, 142-147.
7. Čatár, G., Valent, M. Toxoplazmóza a jej význam v pôrodníctve a gynekológii. Prakt Gynek, 1994, 1, 7-10.
8. Desmonts, G., Couvreur, J., Thuliez, P. Toxoplasmose congénitale. Cinq cas de transmission a ĺ`enfant d`une infection maternelle antérieure a`la grossess. Presse Med, 1990, 19, 1445–1449.
9. Dubey, J. P. Strategies to reduce transmission of Toxoplasma gondii to animals and humans. Vet Parasitol, 1996, 64, 65-70.
10. Dubey, J. P., Beattie, C. P. Toxoplasmosis of animals and man. CRC. Press, 1988, 215s.
11. Dubey, J. P., Lunney, J. K., Shen, S. K., Kwok, O. C. H. et al. Infectivity of low numbers of Toxoplasma gondii oocysts to pigs. J Parasitol, 1996, 82, 438-443.
12. Evans, R. Life cycle and animal infection. In: Ho-Yen DO, Joss AWL. Human Toxoplasmosis. Oxford: Oxford University, Press, 1992, 26-55.
13. Evengard, B., Petersson, K., Engman, M. L., Wiklund, S. Low incidence of toxoplasma infection during pregnancy and newborns in Sweden. Epidemiol Infect, 2001, 127, 121-127.
14. Flegr, J., Havlíček, J. Changes in the personality profile of young women with latent toxoplasmosis. Folia Parasitol (Praha), 1999, 46, 22–28
15. Frenkel, J. K. Biology of Toxoplasma gondii. in: Ambroise-Thomas, P., Peterse, E. Congenital toxoplasmosis: scientific background, clinical management and control. Paris:Springer-Verlag, 2000, 9-25.
16. Galvan-Ramirez, M. L., Soto-Mancilla, J. L., Velasco- Castrejon, O., Perez-Medina, R. Incidencia of anti- Toxoplasma antibodies in women with high risk pregnancy and habitual abortions. Rev Soc Bras Med Trop, 1995, 28, 333-337.
17. Gavinet, M. F., Robert, F., Firtion, G., Delouvrier, E. Congenital Toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol, 1997, 35, 1276-1277.
18. Hall, S. M., Pandit, A., Golwilkar, A., Williams, T. S. How do Jains get Toxoplasma infection? Lancet, 1999, 354, 486-487.
19. Hejlíček, K., Literák, I., Vostálová, E., Kresnická, J. Toxoplasma gondii antibodies in pregnant women in the Ceske Budejovice District. Epidemiol, Mikrobiol, Imunol, 1999, 48, 102-105.
20. Howe, D. K., Sibley, D. Toxoplasma gondii comprises clonal lineages: Correlation of parasite genotype with human disease. J Infect Dis, 1995, 172, 1561-1566.
21. Jackson, M. H., Hutchison, W. M. The prevalence and source of Toxoplasma infection in the environment. Adv Parasitol, 1989, 28, 55-105.
22. Jacquier, P., Hohfeld, P., Vorkauf, H., Zuber, P. Epidemiology of toxoplasmosis in Switzerland: national study seroprevalence monitored in pregnant women 1990-1991. Schweiz Med Wochenschr Suppl, 1995, 65, 29-38.
23. Janitschke, K. Parasitosen toxoplasmose. In: Thomas, L. (eds): Clinical laboratory diagnostics. Use and assessment of clinical laboratory results, TH- Books- Verl-Ges., Frankfurt/Main, 1998, 1323-1324.
24. Jeannel D., Niel G., Costagliola, D., Danis, M. et al. Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol, 1988, 17, 595-602.
25. Jenum, P. A., Kapperud, G., Stray, P. B., Melby, K. K. et al. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect, 1998a,120, 87-92.
26. Jenum, P. A., Stray-Pedersen, B., Melby, K. K., Kapperud, G. et al. Incidence of Toxoplasma gondii infection in 35.940 pregnant Women in Norway and pregnancy Outcome for Infected Women. J Clin Microbiol, 1998b, 36, 2900-2906.
27. Kapperud, G., Jenum, P. A., Stray- Pedersen, B., Melby, K. K. et al. Risk factors for Toxoplasma gondii infection in pregnancy: results of a prospective case-control study in Norway. Am J Epidemiol, 144, 1996, 405-412.
28. Lebech, M., Petersen, E. Neonatal scrrening for congenital toxoplasmosis in Denmark presentation of the desing of a prospective study. Scand J Infect Dis. Suppl, 1992, 84, 75-79.
29. McDonald, J. C., Gyorkos, T. W., Alberton, B., MacLean, J. D. et al. An outbreak of toxoplasmosis in pregnant women in northem Québec. J Infect Dis, 1990, 161, 769-774.
30. Omata, Y., Oikawa, H., Kanda, M., Mikazuki, K. et al. Experimental feline toxoplasmosis: humoral immune responses of cats inokulated orally with Toxoplasma gondii cysts and oocysts. Jpn J Vet Sci, 1990, 52, 865-867.
31. Ondriska, F.: Nový prístup k využitiu ELISA testov v diagnostike toxoplazmózy. Doktorandská dizertačná práca, Bratislava, 2001, 183 s.
32. Paul, M., Petersen, E., Pawlowski, Z. S., Szczapa, J. Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by anlysis of toxoplasma gondii- specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J, 2000, 19, 30-36.
33. Pekeles, G. S., McDonald, J. C., Gyrokos, T. W., Alberton, B. An outbreak of congenital toxoplasmosis in Northem Quebec. Arctic Med Res. Suppl, 1991, 360-362.
34. Petersen, E., Eaton, R. B. Control of congenital infection with Toxoplasma gondii by neonatal screening based on detection of specific immunoglobulin M antibodies eluted from phenylketonuria filter- paper blood- spot samples. Acta Paediatr Suppl, 1999, 88, 36-39.
35. Rai, S. K., Shibata, H., Sumi, K., Rai, G. Toxoplasma antibody prevalence in Nepalese pregnant women and women with bad obstetric history. Southeast Asian J Trop Med Public Health, 1998, 29, 739-743.
36. Roghmann, M. C., Faulkner, C. T., Lefkowitz, A., Patton, S. et al. Decreased seroprevalence for Toxoplasma gondii in Seventh Day Adventists in Maryland. Am J Trop Med Hyg, 1999, 60, 790-792.
37. Sukthana, Y. Difference of Toxoplasma gondii antibodies between Thai and Austrian pregnant women. Southeast Asian J Trop Med Public Health, 1999, 30, 38-41.
38. Tenter, A. M., Heckeroth, A. R., Weiss, L M. Toxoplasma gondii: from animals to humans. Int J Parasitology, 2000, 30, 1217-1258.
39. Thulliez, P. Screening programme for congenital toxoplasmosis in France. Scand J Infect Dis, 1992, 84, (suppl), 43-45.
40. Varella, I. S., Wagner, M. B., Darela, A. C., Nunes, L. M., Müller, R. W. Seroprevalence of toxoplasmosis in pregnant. J Pediatr (Rio J), 2003, 79, 69-74.
41. Vestnik Ministerstva zdravotníctva SR, čiastka 52, roč. 54., č. 106 (z 28.8. 2006). Odborné usmernenie Ministerstva zdravotníctva Slovenskej republiky o diagnostike toxoplazmózy.
42. Walpole, I. R., Hodgen, N., Bower, C. Congenital toxoplasmosis: a large survey in Western Australia. Med J Aust, 1991, 154, 720-724.
43. Wong, S. Y., Remington, J. S. Toxoplasmosis in pregnancy. Clin Infect Dis, 1994, 18, 179–182.
44. Zástěra M., Pokorný J., Jíra J., Valkoun A. Doplněk standardních metodik laboratorní diagnostiky toxoplasmózy. Acta Hyg Epidemiol Microbiol, Příloha č. 3/87, IHE Praha, 1986, 3–14.
45. Zákon č. 577 z r. 2004 Zz. O rozsahu zdravotnej starostlivosti uhrádzanej na základe verejného zdravotného poistenia a o úhradách za služby súvisiace s poskytovaním zdravotnej starostlivosti, v časti preventívna starostlivosť v materstve.
Štítky
Hygiene and epidemiology Medical virology Clinical microbiologyČlánok vyšiel v časopise
Epidemiology, Microbiology, Immunology
2008 Číslo 1
Najčítanejšie v tomto čísle
- Seroprevalence of Toxoplasma gondii among Pregnant Women in Slovakia
- Multidisciplinary Approach to the Management of Vulvovaginal Discomfort
- Detection of Viable Metabolically Active Yeast Cells Using a Colorimetric Assay
- Invasive Pneumococcal Disease in the Czech Republic in 2000-2006